Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
Identifieur interne : 001108 ( Main/Exploration ); précédent : 001107; suivant : 001109Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
Auteurs : Claudia Vellozzi [États-Unis] ; Shahed Iqbal [États-Unis] ; Brock Stewart [États-Unis] ; Jerome Tokars [États-Unis] ; Frank Destefano [États-Unis]Source :
- American journal of public health : (1971) [ 0090-0036 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Facteurs de l'âge, Facteurs de risque, Femelle, Grippe humaine (), Grippe humaine (épidémiologie), Humains, Jeune adulte, Mâle, Pandémies (), Sous-type H1N1 du virus de la grippe A, Sujet âgé, Syndrome de Guillain-Barré (), Syndrome de Guillain-Barré (épidémiologie), Syndrome de Guillain-Barré (étiologie), Tables de survie, Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (usage thérapeutique), États-Unis d'Amérique (épidémiologie).
- MESH :
- effets indésirables : Vaccins antigrippaux.
- usage thérapeutique : Vaccins antigrippaux.
- épidémiologie : Grippe humaine, Syndrome de Guillain-Barré, États-Unis d'Amérique.
- étiologie : Syndrome de Guillain-Barré.
- Pascal (Inist)
- Adulte, Adulte d'âge moyen, Facteurs de l'âge, Facteurs de risque, Femelle, Grippe humaine, Humains, Jeune adulte, Mâle, Pandémies, Polyradiculonévrite de Guillain-Barré, Facteur risque, Risque, Population, 2009, Santé publique, Grippe pandémique, Grippe H1N1, Sous-type H1N1 du virus de la grippe A, Sujet âgé, Syndrome de Guillain-Barré, Tables de survie.
- Wicri :
- geographic : États-Unis.
- topic : Santé publique.
English descriptors
- KwdEn :
- 2009, Adult, Age Factors, Aged, Female, Guillain-Barre Syndrome (epidemiology), Guillain-Barre Syndrome (etiology), Guillain-Barre Syndrome (prevention & control), Guillain-Barré syndrome, H1N1 influenza, Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (adverse effects), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Life Tables, Male, Middle Aged, Pandemics (prevention & control), Pandemics (statistics & numerical data), Population, Public health, Risk, Risk Factors, Risk factor, United States (epidemiology), Young Adult.
- MESH :
- chemical , adverse effects : Influenza Vaccines.
- geographic , epidemiology : United States.
- epidemiology : Guillain-Barre Syndrome, Influenza, Human.
- etiology : Guillain-Barre Syndrome.
- prevention & control : Guillain-Barre Syndrome, Influenza, Human, Pandemics.
- statistics & numerical data : Pandemics.
- chemical , therapeutic use : Influenza Vaccines.
- Adult, Age Factors, Aged, Female, Humans, Influenza A Virus, H1N1 Subtype, Life Tables, Male, Middle Aged, Risk Factors, Young Adult.
Abstract
Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000112
- to stream PascalFrancis, to step Corpus: 000188
- to stream PascalFrancis, to step Curation: 001D07
- to stream PascalFrancis, to step Checkpoint: 000117
- to stream Main, to step Merge: 001118
- to stream Pmc, to step Corpus: 000643
- to stream Pmc, to step Curation: 000643
- to stream Pmc, to step Checkpoint: 000487
- to stream PubMed, to step Corpus: 000875
- to stream PubMed, to step Curation: 000875
- to stream PubMed, to step Checkpoint: 000831
- to stream Ncbi, to step Merge: 001805
- to stream Ncbi, to step Curation: 001805
- to stream Ncbi, to step Checkpoint: 001805
- to stream Main, to step Merge: 000E83
- to stream Main, to step Curation: 001108
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title><author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</s1><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</wicri:noRegion></affiliation></author><author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">14-0118472</idno><date when="2014">2014</date><idno type="stanalyst">PASCAL 14-0118472 INIST</idno><idno type="RBID">Pascal:14-0118472</idno><idno type="wicri:Area/PascalFrancis/Corpus">000112</idno><idno type="stanalyst">FRANCIS 14-0118472 INIST</idno><idno type="wicri:Area/PascalFrancis/Corpus">000188</idno><idno type="wicri:Area/PascalFrancis/Curation">001D07</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000117</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000117</idno><idno type="wicri:doubleKey">0090-0036:2014:Vellozzi C:cumulative:risk:of</idno><idno type="wicri:Area/Main/Merge">001118</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025712</idno><idno type="RBID">PMC:4025712</idno><idno type="wicri:Area/Pmc/Corpus">000643</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000643</idno><idno type="wicri:Area/Pmc/Curation">000643</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000643</idno><idno type="wicri:Area/Pmc/Checkpoint">000487</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000487</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:24524517</idno><idno type="wicri:Area/PubMed/Corpus">000875</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000875</idno><idno type="wicri:Area/PubMed/Curation">000875</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000875</idno><idno type="wicri:Area/PubMed/Checkpoint">000831</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000831</idno><idno type="wicri:Area/Ncbi/Merge">001805</idno><idno type="wicri:Area/Ncbi/Curation">001805</idno><idno type="wicri:Area/Ncbi/Checkpoint">001805</idno><idno type="wicri:doubleKey">0090-0036:2014:Vellozzi C:cumulative:risk:of</idno><idno type="wicri:Area/Main/Merge">000E83</idno><idno type="wicri:Area/Main/Curation">001108</idno><idno type="wicri:Area/Main/Exploration">001108</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic</title><author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</s1><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</wicri:noRegion></affiliation></author><author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</s1><s2>Atlanta, GA</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></analytic><series><title level="j" type="main">American journal of public health : (1971)</title><title level="j" type="abbreviated">Am. j. publ. health : (1971)</title><idno type="ISSN">0090-0036</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">American journal of public health : (1971)</title><title level="j" type="abbreviated">Am. j. publ. health : (1971)</title><idno type="ISSN">0090-0036</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>2009</term><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Guillain-Barre Syndrome (epidemiology)</term><term>Guillain-Barre Syndrome (etiology)</term><term>Guillain-Barre Syndrome (prevention & control)</term><term>Guillain-Barré syndrome</term><term>H1N1 influenza</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Life Tables</term><term>Male</term><term>Middle Aged</term><term>Pandemics (prevention & control)</term><term>Pandemics (statistics & numerical data)</term><term>Population</term><term>Public health</term><term>Risk</term><term>Risk Factors</term><term>Risk factor</term><term>United States (epidemiology)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de l'âge</term><term>Facteurs de risque</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies ()</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Sujet âgé</term><term>Syndrome de Guillain-Barré ()</term><term>Syndrome de Guillain-Barré (épidémiologie)</term><term>Syndrome de Guillain-Barré (étiologie)</term><term>Tables de survie</term><term>Vaccins antigrippaux (effets indésirables)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>États-Unis d'Amérique (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Guillain-Barre Syndrome</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Guillain-Barre Syndrome</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Guillain-Barre Syndrome</term><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Syndrome de Guillain-Barré</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Syndrome de Guillain-Barré</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Life Tables</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Young Adult</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de l'âge</term><term>Facteurs de risque</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies</term><term>Polyradiculonévrite de Guillain-Barré</term><term>Facteur risque</term><term>Risque</term><term>Population</term><term>2009</term><term>Santé publique</term><term>Grippe pandémique</term><term>Grippe H1N1</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Sujet âgé</term><term>Syndrome de Guillain-Barré</term><term>Tables de survie</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objectives. We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic. Methods. We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators. Results. There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS. Conclusions. Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name></region><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001108 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001108 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:14-0118472
|texte= Cumulative Risk of Guillain-Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic
}}
| This area was generated with Dilib version V0.6.34. |  |